摘要
目的:研究高糖刺激下大鼠腹膜间皮细胞分泌叉头状螺旋转录因子(FOXP3mRNA)及苦参碱的干预作用,探讨腹膜纤维化发生机制。方法:通过体外培养大鼠腹膜间皮细胞(PMCs),依据加入药物浓度分成5组:2.5%葡萄糖组(n=10,A);2.5%葡萄糖+苦参碱组(n=10,B);4.25%葡萄糖组(n=10,C);4.25%葡萄糖+苦参碱组(n=10,D);空白对照组(仅加不含血清的DMEM/F12培养基),分别于第24 h、48 h、72 h收集培养上清液,采用RT-PCR检测FOXP3mRNA的表达,同时观察各组大鼠腹膜间皮细胞光镜下的表现。结果:光镜下,可见对照组和B组腹膜间皮细胞小,呈圆形、梭形或不规则形,生长密集。A、C、D组腹膜间皮细胞大、呈梭形、分布较稀疏;在含2.5%高糖A组,FOXP3mRNA的表达相对水平较对照组增加,差异有统计学意义(P<0.05);而在4.25%高糖C组,FOXP3mRNA的表达较对照组增加明显,差异有统计学意义(P<0.01)。在含苦参碱溶液的B组和D组中,PMCs表达FOXP3mRNA的相对水平B组较A组减少,但差异无统计学意义(P>0.05);D组较C组下降明显,差异有统计学意义(P<0.05)。结论:苦参碱能拮抗高糖致大鼠腹膜间皮细胞分泌FOXP3mRNA,从而保护腹膜间皮细胞。
Objective: This study was designed to investigate the effect of matrine on high glucose-induced Forkhead box protein 3( FOXP3mRNA) overexpression in rat peritoneal mesothelial cells( PMCs),and to explore the possible mechanism in the peritoneal fibrosis.Methods: The rat PMCs were incubated in vitro,and then assigned into 5 groups on the basis of the added drug concentrations: 2.5% glucose group( n = 10,A); Glucose + 2.5% matrine group( n = 10,B); 4.25% glucose group( n = 10,C); Glucose + 4.25% matrine group( n = 10,D); Blank control group( added the DMEM / F12 medium).The levels of FOXP3 mRNA in the supernatants were measured by RT-PCR method at the different time( 24 h、48 h、72 h),and observed the changes of PMCs under the microscope.Results: Compared with the groups of A,C,and D,the PMCs in the control group and B group were small,round,spindle,irregular or intensive.The expression of FOXP3mRNA in the A group was lightly higher than that of the control group( P〈0.05),but the level in the C group was significantly higher than that of the control group( P〈0.01).As compared with the A group,The level of FOXP3 mRNA expressed in the B group were decreased( P〈0.05),but the lever in the D group was significantly lower than that of the C group( P〈0.05).Conclusion: Matrine might be helpful to resist the overexpression of FOXP3 mRNA induced by high glucose,and then protect the PMCs.
出处
《中国中西医结合肾病杂志》
2016年第1期22-25,I0003,共5页
Chinese Journal of Integrated Traditional and Western Nephrology
基金
贵阳医学院科研基金(No.K201372)